Treatment for latent tuberculosis has the potential to significantly reduce the incidence of active tuberculosis infection, but patient adherence to treatment regimens is often limited by the lengthy duration of treatment required. This study evaluated the efficacy of a 3-month regimen of rifapentine plus isoniazid administered as directly observed …